Pulmonary vascular resistance and reactivity in children with end-stage cardiomyopathy

Journal of Heart and Lung Transplantation

Volumn 19, Issue 7, 2000, Pages 701-704

  Hughes, Marina L ^a   Kleinert, Sabine ^a   Keogh, Anne ^b   Macdonald, Peter ^b   Wilkinson, James L ^a   Weintraub, Robert G ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOMYOPATHY; CHILD; CHILDHOOD MORTALITY; HEART TRANSPLANTATION; HEMODYNAMIC PARAMETERS; HUMAN; INFANT; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL RATE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; PROGNOSIS; PULMONARY CIRCULATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VASCULAR RESISTANCE;

EID: 0033897342     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00118-2     Document Type: Article

References (14)

1. Addonizio LJ, Gersony WM, Robbins RC, et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 1987;76(supp V):V52-5.
2. Kirklin J.K., Naftel D.C., Kirklin J.W., et al. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 7:1988;331-336.
3. Enriquez-Sarano M., Rossi A., Seward J.B., Bailey K.R., Tajik J. Determinants of pulmonary hypertension in LV dysfunction. J Am Coll Cardiol. 29:1997;153-159.
4. Boffa G.M., Razzolini R., Grassi G., et al. Pulmonary vascular resistance variation over time in candidates for heart transplantation. Am J Cardiol. 73:1994;414-415.
5. Report of the 1995 World Health Organisation/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 93:1996;841-842.
6. Lafarge C.G., Mieltinen O.S. The estimation of oxygen consumption. Cardiovasc Res. 4:1970;23-30.
7. Denfield S.W., Rosenthal G., Gajarski R.J., et al. Restrictive cardiomyopathies in childhood. Etiologies and natural history. Texas Heart Inst J. 24:1997;38-44.
8. Cetta F., O'Leary P.W., Seward J.B., Driscoll D.J. Idiopathic restrictive cardiomyopathy in childhood diagnostic features and clinical course . Mayo Clin Proc. 70:1995;634-640.
9. Pinamonti B., Zecchin M., DiLenarda A., Gregori D., Sinagra G., Camerini F. Persistence of restrictive LV filling pattern in dilated cardiomyopathy an ominous prognostic sign . J Am Coll Cardiol. 29:1997;604-612.
10. Bando K., Konishi H., Komatsu K., et al. Improved survival following pediatric cardiac transplantation in high-risk patients. Circulation. 88:1993;218-223.
11. Zales V.R., Pahl E., Backer C.L., Crawford S., Mavroudis C., Benson D.W. Pharmacologic reduction of pre-transplant pulmonary vascular resistance predicts outcome after pediatric heart transplantation. J Heart Lung Transplant. 12:1993;965-973.
12. Leeman M., Van Cutsem M., Vachiery J.L., Antoine M., Leclerc J.L. Determinants of right ventricular failure after heart transplantation. Acta Cardiol. 51:1996;441-449.
13. Pepke-Zaba J., Higenbottam T.W., Dinh-Xuan A.T., Stone D., Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 338:1991;1173-1174.
14. Adatia I., Perry S., Landzberg M., Moore P., Thompson J.E., Wessel D.L. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol. 25:1995;1656-1664.